Zoetis acquires Neogen

Zoetis Inc., a prominent player in the animal health sector, has announced its agreement to acquire the animal genomics business of Neogen Corporation for $160 million. This acquisition is part of Zoetis' ongoing strategy to boost livestock innovation through enhanced genomics and expand its Precision Animal Health portfolio, underscoring its commitment to delivering advanced care solutions to livestock producers globally.

The deal involves integrating Neogen's genomic technologies and data solutions. Neogen's business, which operates laboratories in the U.S., Brazil, Australia, China, and the UK, caters to clients in over 120 countries. Known for its leadership in U.S. beef and dairy genomics, Neogen provides a robust platform that includes genotyping technologies and software to support data-driven decision-making. This integration is set to enhance genetic testing capabilities, offering deeper insights into animal health, productivity, and sustainability.

According to Jamie Brannan, Zoetis' Chief Commercial Officer, the addition of Neogen’s genomics business aligns with Zoetis' vision to drive innovation through data and technology in animal health. It broadens Zoetis' capacity to deliver predictive insights and personalized care, thus delivering enhanced value to its customers. The strategic move is designed to bolster the company's ability to support sustainable livestock production and improve animal health on a global scale.

This acquisition is set against the backdrop of increasing demands for innovative health solutions within the animal health sector. By incorporating genomics, Zoetis aims to stay competitive and lead in providing cutting-edge health management tools. The move could potentially propel Zoetis ahead of its competitors by leveraging advanced analytical capabilities and setting a new standard in genomics as part of animal care.

The transaction is expected to close in the second half of 2026, contingent upon regulatory approvals and other customary conditions. This timeline sets the stage for Zoetis to integrate Neogen’s capabilities effectively and begin realizing synergies from the acquisition, creating a pivotal shift in its approach to animal health and innovation.